Synapse is going international! A one week event for Master and Ph.D. students to visit and network with company representatives in one of Europe’s leading Life Science clusters.

Synapse is going international again, and YOU can be a part of it!

After the successes of 2016 and 2017, we are happy to announce that Synapse Connect UK 2018 is already in the making. Synapse Connect UK is a week-long international seminar in the United Kingdom during which you will be able to visit the grand life science cluster of London and Cambridge. Through this seminar, you will have the opportunity to learn from world-leading companies the art of transforming an idea to a product in the pharmaceutical industry and how to successfully introduce it to the market. Furthermore, you will discover alternative professional opportunities and network with local students and professionals in a strong international environment that will put Danish students and research back on the map.

The program for SCUK 2017:

The Babraham Institute is an independent charitable life science institute involved in biomedical research, set in an extensive parkland estate (The Babraham Research Campus). It is a cluster of highly prestigious research groups and developing start-ups.
Is a multinational biotechnology company specializing in discovery, development and delivery of therapies for the treatment of neurodegenerative, hematologic and autoimmune diseases.
Crescendo biologics is discovering and developing potent and highly differentiated Humanbody® therapeutics with a foucs on key cancer indications with a high unmet need.
Software innovation company with focus in life science research. They develop several tools that help on the design and following of research experiments (e.g. reducing the complexities of the CRISPR technique).


The European Molecular Biology Laboratory is a molecular biology research institution supported by 22 member states, four prospect and two associate member states. It is an intergovernmental organization funded by public research money from its member states. We will visit EMBL-EBI (The European Bioinformatics Institute), which is the center for research and services in bioinformatics.
F-star is a company based at Babraham Institute in Cambridge that develops novel bispecific therapeutic antibodies targeting cancers and other serious diseases. This allows for targeting of yet unknown combinations of targets. Other bispecific antibodies are on the market, but none of them use modular antibodies that can be put together to form a bispecific antibody. This allows for a very flexible approach to antibody discovery and development with ease of manufacturing and developing new therapeutics.
GlaxoSmithKline is a British pharmaceutical company with a broad pipeline of drug development and commercialization which has led it to be on the top 10 biggest pharmaceutical companies world-wide, with a revenue of around £ 34 billion as in 2014 and nearly 100.000 employees.
London-based university consistenty ranked among the top universities in the world. In 2015 it was ranked the most innovative university in Europe and in 2017 it was the 5th most international university in the world.
Swiss multinational chemicals and biotechnology company that provides product development services to the pharmaceutical and biologic industries, including organic, fine and performance chemicals, custom manufacturing of pharmaceuticals, chemical synthesis capabilities and detection systems and services for the bioscience sectors.
Subsidiary of AstraZeneca focused in biotechnology development. It has one of the largest, most robust pipelines in the industry, comprising nearly half of AstraZeneca’s overall R&D portfolio. Focused in three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease. They also have some Infectious Disease projects.
Is a British student-driven organization which aims to provide a first of its kind globally interconnected communication, networking and training platform between academia, industry and society. It is the British version of Synapse!
Synthetic Biology community with the aim of aiding students and professionals to engage with research, commercial, social and outreach aspects of Synthetic Biology. Based at Imperial College London.
London-based university with the largest postgraduate institution in the UK by enrollment and regarded as one of the world’s leading multidisciplinary research.
Second-oldest university in the English-speaking world and consistently ranked as one of the world’s best universities. It has educated many notable alumni, including 95 Nobel laureates.
The Wellcome Trust is the world’s second largest charitable foundation in the field of medical research, both politically and financially independent. They support scientists and researchers, take on big problems, fuel imaginations and spark debate.
Non-profit British genomics and genetics research institute funded by the Wellcome Trust in close contact with EMBL-EBI and mostly known for being a large scale DNA sequencing center that participated in the Human Genome Project, to which made the largest single contribution to the gold standard sequence of the human genome.

More information on the dates and programme for the 2018 seminar will follow - but it will consist of company visits and workshops at:

  • Universities
  • Biotech companies
  • Pharmaceutical industry leaders
  • Innovation hubs
  • Venture capital firms
  • Cluster organizations
  • And much more!

And of course, a lot of social activities with other Danish students as well as networking events with local students and professionals.

We will require:
- a Cover Letter (in English!) of approximately one page explaining why you want to join this event and what you can add to the team we will send to the UK;
- a CV (also in English) of max. 2 pages.
You need to study or work in Denmark or Southern Sweden in order to attend this event. Newly graduates that reside in these areas are also welcome to apply.

- Seminar will be held in spring 2018. Dates will follow.

- The group will be formed by 40 life science students (Bachelor, Master and PhD) as well as young professionals from Danish and Southern Swedish universities, of which some Synapse members will be joining as arrangers.

- The application period is expected to open in December 2017.

- There will be a fee for each participant of approximately DKK3000 depending on fares. This fee will include transportation to and from the UK, housing and all transportation required for the seminar (airport - housing -company visits etc.). It will also include all breakfasts and some additional meals.

If you have any questions you can send an email to


In Spring 2016, we launched our first Synapse Connect event. During Synapse Connect UK ‘16, a large group of ambitious and competent students were welcomed into the Life Science milieu of one of the most prominent Life Science clusters in Europe, the Cambridge/London area. This successful event was filled with networking events and interactions among our participants, British university students, and corporate representatives, and has also led to a strong professional connection among the Danish participants. Hence, this Connect trip has become the first of a new annual tradition!

So are you wondering what your future holds, and are you looking for an international angle on your future job in the industry? Then join us for Synapse Connect next Spring and learn more about entrepreneurial tactics, cancer immunotherapy, pharmacological research, alternative job opportunities, recruitment tactics for new graduates, the legal background of law firms in the life sciences, and much much more.

Spring 2018 - We are making the UK success even better! 

Spring 2019 - Which Life Science cluster do you want to visit?





Spring 2019 - Which life science clusters do you want to visit?

Join if you are interested in:

  • diving into the process of product development with top strategic companies
  • discovering alternative career opportunities outside of academia
  • being part of new national and international Life Science networks.



In April 2016, Synapse brought 40 ambitious and competent Master students, PhD students, and newly graduates to the Life Science clusters of Cambridge and London. In 5 intense days of visiting and networking with company professionals, participants became familiar with the newest knowledge in the fields of cancer immunotherapy, pharmacological research, alternative job opportunities, recruitment tactics for new graduates, and the legal background of law firms in the Life Sciences. Furthermore, students were invited to attend a Formal Hall dinner in one of the oldest houses of University of Cambridge along with professors and students of their leading entrepreneurial degree, Master of Bioscience Enterprise.

The 2016 visit has not only established new contacts within international companies and associated Danish branches, but has also created a strong network among the brilliant and top motivated Danish participants, who are all pursuing a career in tomorrow’s leading Life Science industry.

Sponsors of Earlier Events



SCUK’16 Brochure